Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: September 15, 2026 at 1:11 AM UTC
| NCT Number | NCT07686263 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 472 participants |
| Active Locations | 34 sites in the US |
| Sponsor | Karuna Therapeutics, Inc., a Bristol Myers Squibb company |
| Last Updated on CT.gov | September 14, 2026 (Yesterday) |
As of September 15, 2026: Clinical trial NCT07686263 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 34 locations across the United States. The study is sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07686263 is actively recruiting participants as of September 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07686263 was last updated Yesterday (September 14, 2026). HelloStudys verifies this status automatically.